Analyst Reco. argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Market Closed - Euronext Bruxelles Other stock markets 11:55:00 2025-12-12 EST			5-day change	1st Jan Change
753.20 ^EUR	-0.48%		-2.31%	+25.53%

12-04	KBC Securities Upgrades Argenx to Buy, Boosts PT	MT
12-02	European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading	MT

Analyst Reco.

KBC Securities Upgrades Argenx to Buy, Boosts PT	12-04	MT
Wolfe Research Downgrades argenx to Peer Perform From Outperform	11-24	MT
Wedbush Raises Price Target on argenx to $1,000 From $880, Keeps Outperform Rating	11-14	MT
Wedbush Raises Price Target on argenx to $880 From $800, Keeps Outperform Rating	10-13	MT
Argenx's Broader Pipeline Value Underappreciated, Morgan Stanley Says	10-01	MT
Morgan Stanley Raises Price Target on Argenx to $1,040 From $766, Keeps Overweight Rating	10-01	MT
The stock market regains its cloak of invincibility	09-12
William O'Neil & Co Begins Argenx Coverage at Buy	08-26	MT
Argenx's Vyvgart Uptake is Likely to Accelerate, RBC Says	08-25	MT
Bank Degroof Petercam Raises Argenx PT, Maintains at Buy	08-25	MT
RBC Initiates Argenx at Outperform With $850 Price Target	08-25	MT
Morgan Stanley Raises Price Target on argenx SE to $766 From $700, Keeps Overweight Rating	08-01	MT
Deutsche Bank Upgrades Argenx to Buy, Raises PT	07-08	MT
Baird Upgrades argenx to Outperform From Neutral, Price Target is $680	05-13	MT
Bernstein Upgrades argenx to Outperform, Boosts PT	03-17	MT
Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says	02-28	MT
Wedbush Raises Argenx's Price Target to $665 From $655, Maintains Outperform Rating	12-27	MT
Oppenheimer Adjusts argenx SE ADR Price Target to $675 From $646, Maintains Outperform Rating	11-21	MT
Morgan Stanley Raises Price Target on argenx to $675 From $580, Keeps Overweight Rating	11-18	MT
Wolfe Research Upgrades argenx SE ADR to Outperform From Peer Perform, $697 Price Target	11-12	MT
Scotiabank Upgrades argenx to Sector Outperform From Sector Perform, Price Target is $715	11-05	MT
Baird Downgrades argenx to Neutral From Outperform, Adjusts Price Target to $650 From $515	11-01	MT
William Blair Upgrades argenx to Outperform From Market Perform	11-01	MT
Evercore ISI Raises Price Target on argenx to $555 From $533, Keeps Outperform Rating	24-08-26	MT
KBC Securities Downgrades Argenx to Accumulate, Lifts PT	24-08-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. argenx SE

Equities

ARGX

NL0010832176

Biotechnology & Medical Research

Analyst Reco.

Filters